🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was a randomized controlled trial to compare the ...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2015-01
Trial ID
NCT02557490
Treatments Being Tested
The primary study objective is to evaluate improvement of symptoms from ben...
Status
Withdrawn
Location
Stanford University
Start Date
2017-10-14
Trial ID
NCT03179228
Treatments Being Tested
The primary purpose of this study is to compare pain after uterine artery e...
Status
Unknown
Location
Severance Hospital, Yonsei University Health System
Start Date
2021-07
Trial ID
NCT04960293
This study is being done to determine if it is safe to perform lung chemoem...
Status
Completed
Location
Memoral Sloan Kettering Monmouth (Consent only)
Start Date
2019-12-13
Trial ID
NCT04200417
Treatments Being Tested
The purpose of this prospective randomized controlled study is to compare t...
Status
Withdrawn
Location
Hospital Universitario Lozano Blesa
Start Date
2015-10
Trial ID
NCT02566551
Treatments Being Tested
The primary purpose of this study is to compare pain after uterine artery e...
Status
Completed
Location
Sesverance Hospital, Yonsei University College of Medicine
Start Date
2018-04-19
Trial ID
NCT03420248
Treatments Being Tested
The purpose of this study is to determine if TACE plus Sorafenib will impro...
Status
Terminated
Location
University of Pittsburgh Cancer Institute
Start Date
2008-01
Trial ID
NCT00576056
This study intends to evaluate the efficacy and safety of Transarterial emb...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2016-05
Trial ID
NCT02964260
Treatments Being Tested
This randomized phase III trial studies how well transarterial chemoemboliz...
Status
Terminated
Location
Stanford University, School of Medicine
Start Date
2016-02-27
Trial ID
NCT02762266
Treatments Being Tested
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the thir...
Status
Recruiting
Location
Sichuan Cancer Hospital and Research Institute
Start Date
2024-08-10
Trial ID
NCT06485466
Treatments Being Tested